Advanced company searchLink opens in new window

TENPOINT THERAPEUTICS LIMITED

Company number 12862607

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Sep 2021 AP01 Appointment of Mr Nihal Sinha as a director on 1 December 2020
26 Aug 2021 AA01 Current accounting period extended from 30 September 2021 to 31 December 2021
29 Mar 2021 PSC08 Notification of a person with significant control statement
29 Mar 2021 PSC07 Cessation of Vanessa King as a person with significant control on 15 October 2020
26 Mar 2021 PSC07 Cessation of Lyndon Da Cruz as a person with significant control on 1 December 2020
26 Mar 2021 PSC07 Cessation of Peter John Coffey as a person with significant control on 1 December 2020
28 Jan 2021 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
28 Jan 2021 MA Memorandum and Articles of Association
14 Jan 2021 SH01 Statement of capital following an allotment of shares on 24 December 2020
  • GBP 914.8855
04 Jan 2021 AP01 Appointment of Anta Gkelou as a director on 1 December 2020
04 Jan 2021 AP01 Appointment of Anna Louise French as a director on 1 December 2020
04 Jan 2021 AP01 Appointment of Jiaping Gu as a director on 1 December 2020
22 Dec 2020 SH01 Statement of capital following an allotment of shares on 1 December 2020
  • GBP 274.8855
17 Dec 2020 AP01 Appointment of Alexander Thomas Pasteur as a director on 1 December 2020
14 Dec 2020 AP01 Appointment of Graziano Seghezzi as a director on 1 December 2020
  • ANNOTATION Clarification a second filed AP01 was registered on 20/09/21
25 Nov 2020 CERTNM Company name changed tenzing therapeutics LIMITED\certificate issued on 25/11/20
  • CONNOT ‐ Change of name notice
10 Nov 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
06 Nov 2020 SH01 Statement of capital following an allotment of shares on 15 October 2020
  • GBP 215.2749
07 Sep 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2020-09-07
  • GBP 170.5669